Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded
- Contract number
- SPE2DB25FU9KV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,317
Award facts
- Contract value 100% obligated
- $27,316.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Dupixent 300 mg/2 mL syringes valued at $27,316.87 with a firm fixed price. The contract is set to be completed by June 20, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999 through December 2026, which enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was competitively awarded this delivery order without set-aside designation. The company serves as a critical vendor for federal medical procurement, supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Dupixent is a biologic treatment for conditions including atopic dermatitis, asthma, and chronic rhinosinusitis, reflecting the company's role in providing specialized pharmaceutical products to support military personnel and veteran healthcare needs.
Quick answers
Who was awarded contract SPE2DB25FU9KV?
SPE2DB25FU9KV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 18, 2025.
How much is contract SPE2DB25FU9KV worth?
The government has obligated $27,317 on SPE2DB25FU9KV.
Is contract SPE2DB25FU9KV an order under another contract?
Yes. SPE2DB25FU9KV is a delivery order under SPE2DB22D1052, an indefinite delivery contract.
Was contract SPE2DB25FU9KV competed?
The extent of competition for SPE2DB25FU9KV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award